Relyea Zuckerberg Hanson’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,129
| Closed | -$229K | – | 265 |
|
|
2024
Q3 | $229K | Buy |
11,129
+176
| +2% | +$3.62K | 0.03% | 230 |
|
|
2024
Q2 | $245K | Sell |
10,953
-23
| -0.2% | -$515 | 0.04% | 208 |
|
|
2024
Q1 | $302K | Sell |
10,976
-2,242
| -17% | -$61.7K | 0.05% | 181 |
|
|
2023
Q4 | $403K | Buy |
13,218
+2
| +0% | +$61 | 0.08% | 132 |
|
|
2023
Q3 | $418K | Sell |
13,216
-97
| -0.7% | -$3.07K | 0.1% | 119 |
|
|
2023
Q2 | $543K | Sell |
13,313
-80
| -0.6% | -$3.26K | 0.12% | 105 |
|
|
2023
Q1 | $499K | Buy |
13,393
+20
| +0.1% | +$745 | 0.12% | 101 |
|
|
2022
Q4 | $467K | Buy |
13,373
+149
| +1% | +$5.2K | 0.13% | 105 |
|
|
2022
Q3 | $740K | Buy |
13,224
+16
| +0.1% | +$895 | 0.27% | 58 |
|
|
2022
Q2 | $684K | Buy |
13,208
+2
| +0% | +$104 | 0.25% | 62 |
|
|
2022
Q1 | $832K | Buy |
+13,206
| New | +$832K | 0.27% | 60 |
|